Pfizer, Inc. (NYSE: PFE) declared a quarterly dividend of $0.26 per share, or $1.04 annualized.The dividend will be payable on June 3, 2014, to stockholders of record on May 9, 2014, with an ex-dividend date of May 7, 2014.Pfizer Inc. (NYSE:PFE) shares after opening at $30.73 moved to $30.80 on last trade day and at the end of the day closed at $30.75. Company price to sales ratio in past twelve months was calculated as 3.81 and price to cash ratio as 6.07. Pfizer Inc. (NYSE:PFE) showed a positive weekly performance of 1.65%.
Boston Scientific Corporation (NYSE:BSX) is a maker and provider of medical devices that are mainly employed in interventional medical situations. The company carries a market value of more than $18 billion.It just improved its product portfolio following FDA approval of its latest heart failure and defibrillators that aim to advance care for patients with life-threatening conditions. The newly approved technologies include DYNAGEN X4, INOGEN MINI ICDs and DYNAGEN MINI. Boston Scientific Corporation (NYSE:BSX) shares fell -2.69% in last trading session and ended the day on $13.38. BSX return on equity ratio is recorded as -1.80% and its return on assets is -0.70%. Boston Scientific Corporation (NYSE:BSX) yearly performance is 77.45%.
Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) is an Israel-based drug company. The generic drug companies are giving TEVA a tough competition. The generic companies are developing a cheaper version of the blockbuster drug by TEVA called Copaxone. Teva is trying its best to stop the generic companies from developing the cheaper versions. Till date the company has failed in its attempts to stop the generic drug makers, To protect its drug from generic manufacturers, the company has appealed with the U.S. top court. The company is putting so much effort of block to the generic manufacturer because the drug gives Teva pharma sale of nearly $3.2 billion.Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares moved down -2.31% in last trading session and was closed at $48.69, while trading in range of $48.35-$50.07. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) year to date performance is 22.40%.
HCA Holdings (NYSE:HCA) has received a consensus recommendation of “Buy” from the twenty ratings firms that are currently covering the stock. Three investment analysts have rated the stock with a hold recommendation, fifteen have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among brokerages that have covered the stock in the last year is $51.60. HCA Holdings Inc (NYSE:HCA) weekly performance is 9.04%. On last trading day company shares ended up $57. HCA Holdings Inc (NYSE:HCA) distance from 50-day simple moving average is 7.16%. Analysts mean target price for the company is $57.48.